Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-28

Clinical Trial Update: Gamma tACS in Attention-Deficit/Hyperactivity Disorder [NA]

View source ↗

Summary

A clinical trial update indicates a study of gamma frequency transcranial alternating current stimulation (tACS) for attention-deficit/hyperactivity disorder is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gamma tACS (gamma frequency transcranial alternating current stimulation)

Snippet

Sponsor: Medipol University | Conditions: Attention Deficit Disorder With Hyperactivity (ADHD) | NA | Status: ENROLLING_BY_INVITATION